Dichloromethane → HCID 86687577, compound
Reaction equation
[C:1]([C:3]1[CH:4]=[N:5][C:6]2[C:11]([C:12]=1[C:13]1[CH:18]=[CH:17][CH:16]=[CH:15][C:14]=1[O:19][CH3:20])=[CH:10][CH:9]=[C:8]([S:21]([N:24](CC1C=CC(OC)=CC=1)[C:25]1[S:26][CH:27]=[CH:28][N:29]=1)(=[O:23])=[O:22])[CH:7]=2)#[N:2].C(Cl)Cl.C(O)(C(F)(F)F)=O>CO>[C:1]([C:3]1[CH:4]=[N:5][C:6]2[C:11]([C:12]=1[C:13]1[CH:18]=[CH:17][CH:16]=[CH:15][C:14]=1[O:19][CH3:20])=[CH:10][CH:9]=[C:8]([S:21]([NH:24][C:25]1[S:26][CH:27]=[CH:28][N:29]=1)(=[O:23])=[O:22])[CH:7]=2)#[N:2]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
A vial was charged with 3-cyano-N-(4-methoxybenzyl)-4-(2-methoxyphenyl)-N-(thiazol-2-yl)quinoline-7-sulfonamide (23.3 mg, 0.043 mmol), DCM (0.5 mL), and TFA (0.25 mL). After 30 min, the mixture was diluted with MeOH and concentrated, and the crude product was purified by chromatography on silica gel (12-g Redi-Sep Gold column, 0-5% MeOH/DCM) to give 3-cyano-4-(2-methoxyphenyl)-N-(thiazol-2-yl)quinoline-7-sulfonamide (13.6 mg, 0.032 mmol, 75.0% yield) as a light-yellow solid. 1H NMR (400 MHz, DMSO-d6) δ=12.99 (br. s., 1H), 9.35 (s, 1H), 8.50 (d, J=1.8 Hz, 1H), 7.98 (dd, J=1.9, 8.8 Hz, 1H), 7.72 (d, J=8.9 Hz, 1H), 7.67-7.58 (m, 1H), 7.40 (dd, J=1.7, 7.5 Hz, 1H), 7.35-7.28 (m, 2H), 7.21 (dt, J=0.8, 7.5 Hz, 1H), 6.89 (d, J=4.6 Hz, 1H), 3.71 (s, 3H). m/z (ESI) 423.2 (M+H)+.
Workup
- concentrationconcentrated
- customthe crude product was purified by chromatography on silica gel (12-g Redi-Sep Gold column, 0-5% MeOH/DCM)
Sources & evidence
- ORD record
- ord-ee57606d84f3415c8caf67b85efc2800
- Source dataset
- uspto-grants-2015_04
- Patent number
- US09012443B2
Reaction notes
Loading…